USANA - Public Comps and Valuation Multiples

USANA Overview

About USANA

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

Founded

1992

HQ

Employees

1.7K+

Website

usana.com

Sectors

Food & Beverages

Financials

LTM Revenue $885M

LTM EBITDA $110M

EV

$309M

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

USANA Financials

USANA has a last 12-month revenue of $885M and a last 12-month EBITDA of $110M.

In the most recent fiscal year, USANA achieved revenue of $855M and an EBITDA of $98.9M.

USANA expects next 12-month revenue of XXX and NTM EBITDA of XXX

See USANA valuation multiples based on analyst estimates

USANA P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$921M	$855M	XXX	XXX	XXX
Gross Profit	$805M	$744M	XXX	XXX	XXX
Gross Margin	87%	87%	XXX	XXX	XXX
EBITDA	$123M	$98.9M	XXX	XXX	XXX
EBITDA Margin	13%	12%	XXX	XXX	XXX
Net Profit	$69.3M	$63.8M	XXX	XXX	XXX
Net Margin	8%	7%	XXX	XXX	XXX
Net Debt	n/a	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

USANA Stock Performance

As of April 15, 2025, USANA's stock price is $24.

USANA has current market cap of $462M, and EV of $309M.

See USANA trading valuation data

USANA Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$309M	$462M	XXX	XXX	XXX	XXX	$2.64

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

USANA Valuation Multiples

As of April 15, 2025, USANA has market cap of $462M and EV of $309M.

USANA's trades at 0.3x LTM EV/Revenue multiple, and 2.8x LTM EBITDA.

Analysts estimate USANA's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for USANA and 10K+ public comps

USANA Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$309M	XXX	XXX	XXX
EV/Revenue	0.4x	XXX	XXX	XXX
EV/EBITDA	3.1x	XXX	XXX	XXX
P/E	11.0x	XXX	XXX	XXX
P/E/Growth	0.6x	XXX	XXX	XXX
EV/FCF	6.1x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get USANA Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

USANA Valuation Multiples

USANA's NTM/LTM revenue growth is 11%

USANA's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.4M for the same period.

Over next 12 months, USANA's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate USANA's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for USANA and other 10K+ public comps

USANA Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	-7%	XXX	XXX	XXX	XXX
EBITDA Margin	12%	XXX	XXX	XXX	XXX
EBITDA Growth	-20%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	22%	XXX	XXX	XXX	XXX
Revenue per Employee	$0.5M	XXX	XXX	XXX	XXX
Opex per Employee	$0.4M	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	31%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
Opex to Revenue	73%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry